sur BASTIDE (EPA:BLC)
Sustained Growth for Bastide in the 3rd Quarter of 2024-2025
The Bastide Group reported revenue of €144.2 million for the third quarter of 2024-2025, representing organic growth of 7.7%. This momentum is driven by home healthcare services, particularly in the Respiratory and Nutrition-Infusion-Stoma Therapy segments, which posted increases of 10.4% and 7.3% respectively.
Over a nine-month period, revenue reached €419.4 million, representing an 8.4% increase compared to the previous year. Home care also contributed, with revenue of €150.8 million, up 4.2%.
These results allow the group to confirm its objectives for 2024-2025, with a targeted turnover of at least €560 million and an operating margin of 9.1% or more. Strict management of working capital requirements and investments is a lever for improving its debt ratios.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BASTIDE